However, consistent with our hypothesis, the results of GSEA using the androgen responsive gene set demonstrated that the expression of candidate genes accurately reflects a larger gene signature representing tumor AR activity in all breast cancer subtypes (Fig. 5a–c). This evidence concerns the gene AR and breast carcinoma.